Loading clinical trials...
Loading clinical trials...
This study is being conducted to collect additional long-term efficacy and safety data of Aldurazyme® (laronidase) patients with MPS I disease. Patients who were previously enrolled in the Phase 3 Dou...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genzyme, a Sanofi Company
Collaborators
NCT02254863 · Adrenoleukodystrophy, Batten Disease, and more
NCT03153319 · Mucopolysaccharidosis I, Mucopolysaccharidosis II, and more
NCT03488394 · Mucopolysaccharidosis IH
NCT04348136 · Mucopolysaccharidosis II
NCT05422482 · Mucopolysaccharidosis II, Hunter Syndrome
University of South Alabama
Mobile, Alabama
Emory University School of Medicine
Atlanta, Georgia
University of Rochester
Rochester, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions